Related Experiment Video

Updated: May 30, 2026

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

Lack of recurrence of imatinib-induced interstitial lung disease with nilotinib

Thomas Delomas, Christian Darné, Caroline Besson

    Leukemia & Lymphoma
    |August 10, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Concept Videos